Monitored source Updated every 6h
BioPharma Dive
BioPharma Dive is an industry-news source covering pharma biotech that ScopePlex monitors daily for construction-phase signals. 14 public signals tracked.
BioPharma Dive has contributed 14 public, confidence-scored construction signals tracked by ScopePlex. As an industry-news source, it surfaces pharma biotech construction activity — awards, financings, and groundbreakings — that ScopePlex cross-checks against primary records before a signal is published. For BD teams at specialty contractors, watching this source is one input into knowing which pharma biotech projects are entering the window where subcontract relationships are won — before the formal RFP.
Signals tracked
14
Class
industry news
Type
rss
Related sources in Pharmaceutical & Biotech
Recent public signals from this source
Jul 27
Argenx to acquire Forte in $2.2B deal for ‘differentiated’ immune drug
Jul 21
Tempus to acquire cancer test maker Personalis for $1.5B
Jul 1
Ipsen’s $450M blood cancer drug; FDA selects first cohort for “pre-check” pilot program
Jun 22
AbbVie to acquire Apogee, staking nearly $11B on long-acting autoimmune drugs
Jun 11
Novartis RNA drug acquired in $12B Avidity deal notches a trial win
Jun 9
GSK boosts cancer pipeline with $11B Nuvalent buyout
Jun 8
J&J to acquire Firefly, maker of ‘degrader’ antibody drugs, for $1B
Jun 1
Servier buys into muscular dystrophy with potentially $2.7B deal
May 8
Lilly to invest extra $4.5B across Indiana manufacturing
May 7
Roche to acquire digital pathology firm PathAI in deal potentially worth over $1B
May 6
Bayer to buy Perfuse for up to $2.45B, bolstering eye drug pipeline
Apr 23
Drugmaker AbbVie chooses North Carolina for $1.4B manufacturing campus
Apr 22
Merck adds to pharma’s AI push; Roche details MS drug results
Apr 20
Lilly boosts ‘in vivo’ cell therapy capabilities with Kelonia buyout
Gated intelligence
The facts are public. The intelligence is behind signup.
- Confidence score on every signal
- "Why it matters" — the BD read on each move
- Timing window & who to call
- Your curated daily brief, filtered to your sectors
- Saved pursuits, company watchlists & alerts
Unlock BioPharma Dive intelligence →7-day trial · no card required